Incyte awarded the Massachusetts General Cancer Center as the recipient of its first Incyte Ingenuity Award, which is given to innovative programs created to support people living with GVHD. The center will receive $100,000 to implement its project called Horizon Mobile App for Patients with Chronic GVHD.

According to a press release from Incyte, the app is a patient-centered, multi-component mobile intervention app that aims to improve the quality of life and care of patients with chronic GVHD.

“We are honored to receive the Incyte Ingenuity Award, which will support our institution’s efforts to help advance care for GVHD patients,” said Areej El-Jawahri, M.D., Director of the Bone Marrow Transplant Survivorship Program, Massachusetts General Cancer Center. “Specifically, this award will allow us to support our chronic GVHD patients, who represent a vulnerable population that experiences high degrees of physical and functional limitations, impaired quality of life and significant psychological distress, by developing an app focused on the essential self-management and coping skills that are critical to improving their lives.”

Read more on Business Wire.

Tags: